Larry Weiner

Larry Weiner is Enzyvant’s Senior Vice President of Pharmaceutical Development and Manufacturing. In this role, Larry was instrumental in securing FDA commercial approval for RETHYMIC® and leads CMC operations activities and is responsible for the delivery of a new internal manufacturing facility.

Previously, Larry was the Vice President of Technical Operations & CMC at Unum Therapeutics, a cell therapy company. Other experience includes engineering, program management, process development and manufacturing leadership roles at Biogen, MassBiologics, Pfizer, Serono, Indigo Ag and Amgen. He has led and supported cell therapy, gene therapy, biologics, oligonucleotides, tissue therapy, blood fraction and vaccines strategy development, cGMP operations and regulatory inspections.

Larry has a Bachelor of Science in Chemical Engineering from Tufts University, an MBA from Babson College and a Masters in Bioengineering from Tufts University. Larry serves on the Tufts University Department of Chemical and Biological Engineering Advisory Board.